Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

>> Preview...

Time Runs Out on Bayer-Topsun Deal

publication date: Feb 28, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Topsun Technology (SHA: 600771) said its agreement with Bayer AG of Germany (XE: 575200) has expired. On October 25, 2006, Bayer agreed to pay 1.072 billion RMB (currently equivalent to $146 million) for the White and Black Brand of OTC drugs from Topsun, which includes three cold remedies: Bai Jia Hei, Xiao Bai, and Xin Li. The deal was subsequently approved by China’s Ministry of Commerce on October 17, 2007, almost one year after being announced. More details...

Stock Symbols: (SHA: 600771) (XE: 575200)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events

ChinaBio® Partnering Forum 2013
  May 29-30, 2013
Beijing, China

>>More events...
Partner Events

China Medical Affairs Summit
  June 18-19, 2013
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners